TI
Thrombolex, Inc.
SEC filingOther Health Care · Kingston, NJ
Amount raised$32.8Msold at filing
Total offering$51.1M$18.3M still open
Investors in the raise22count reported to the SEC
FiledMar 12, 2026first sale Feb 26, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David A. BonitaDirector
Keegan A. HarperDirector
Paul A. StewartDirector
Sam A. LiangDirector
Marvin J. WoodallExecutive Officer, Director
John J. CerminaroExecutive Officer
Clay A. DeMarcusDirector
Michael J. CerminaroExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.